Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
New Caledonia has one of the highest rates of end-stage kidney disease treated by dialysis (2384 per million inhabitants in 2024, vs. 1362 per million in mainland France in 2022), with over 60% of patients being diabetic. Neurovascular foot ulcers are frequent, often detected late, and may lead to avoidable amputations. This initiative aimed to enhance early detection of foot lesions during dialysis sessions through a multidisciplinary care model.
A professional practice evaluation was implemented in July 2022 across two dialysis units (a main center and a mixed unit). Patients with risk factors (hypertension, peripheral arterial disease, or diabetes) underwent a standardized screening protocol including visual inspection, risk grading according to HAS (French National Health Authority) guidelines, Doppler evaluation, and podiatry referral when indicated. A city–hospital nursing network was established, and a dedicated wound-monitoring module was integrated into the electronic medical record. Three screening campaigns were conducted between February 2023 and February 2025, targeting arterial ulcers, plantar perforating ulcers, and calciphylaxis.
Among 286 identified at-risk patients, 174 (61%) were screened. Participants were 52% male, with a mean age of 65 ± 12 years and a mean dialysis duration of 4 ± 4 years; 82% had hypertension, 79% diabetes, and 26% peripheral arterial disease. Thirteen patients (7%) presented with an active ulcer. While the proportion of ulcer-related hospitalizations remained stable (6% in 2022 vs. 9% in 2023–2024; p = 0.64), the mean hospital stay for ulcer management was halved (57.5 vs. 28.0 days; p = 0.06).
This multidisciplinary foot-screening program in hemodialysis patients proved both feasible and clinically relevant, given the high vascular morbidity in this population. Close collaboration between dialysis nurses, podiatrists, dieticians, angiologists, vascular surgeons and of course nephrologists improved coordination of care and may help prevent severe complications such as infection or amputation. The complementary use of rheopheresis for refractory microvascular lesions further strengthens this preventive strategy, aiming to optimize patient outcomes through an integrated and proactive approach. This structured, multidisciplinary screening approach enhanced early detection and management of neurovascular foot ulcers in hemodialysis patients. Preliminary results suggest a reduction in hospitalization duration and better care coordination. Ongoing follow-up will assess the long-term benefits and confirm the impact on morbidity and limb preservation.
This abstract was previously presented as a poster at the 2025 SFNDT Congress in Tours, France. Re-submission of this abstract to WCN’26 is permitted by the organizers of the original meeting.
